Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
28 pending office actions • 19 art units • 24 examiners • 0 of 28 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (11%) |
| §103 only | 8 (29%) |
| §112 only | 4 (14%) |
| Double-patenting only | 1 (4%) |
| Double-patenting + other | 3 (11%) |
| Multi-statute (no §101) | 8 (29%) |
| No statute on record | 1 (4%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AKAR, SERKAN | 4 | 66.0% | +33.7% |
| STAVROU, CONSTANTINA E | 2 | 43.7% | +36.9% |
| TALUKDER, MD K | 1 | 80.0% | +14.3% |
| NEWTON, CHAD A | 1 | 37.6% | +23.2% |
| CHNG, JOY POH AI | 1 | 60.6% | +19.0% |
| WILSON, JERICA KATLYNN | 1 | 61.4% | +39.1% |
| FONTAINHAS, AURORA M | 1 | 37.9% | +49.2% |
| MOSHER, ERIC PARKER | 1 | 100.0% | +0.0% |
| UNDERDAHL, THANE E | 1 | 58.8% | +50.8% |
| CHASE, CAROL ANN | 1 | 42.6% | +84.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18578888 | PORPHYRIN NANOVESICLE WITH FATTY ACID CONJUGATE | MOSHER, ERIC PARKER | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18044288 | METHODS FOR GENERATING NEURAL PROGENITOR CELLS WITH A SPINAL CORD IDENTITY | CONNORS, ALEXANDRA F | 45d overdue |
| 17924040 | METHODS AND COMPOSITIONS FOR MAKING AND USING ENDOCARDIAL CELLS | ROGERS, ERIC JASON | 21d |
| 17620103 | FUROSEMIDE ANALOGUES AND COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ALZHEIMER'S DISEASE | CHENG, KAREN | 23d |
| 18908568 | SYSTEM AND METHOD FOR REMOTE PATIENT MONITORING | NEWTON, CHAD A | 34d |
| 18899233 | NEUROTECHNOLOGY SYSTEM AND METHOD FOR MONITORING SEIZURE DEVELOPMENT AND ASSESSING ANTI-SEIZURE DRUG RESPONSE | CHNG, JOY POH AI | — |
| 18684053 | METHODS AND COMPOSITIONS FOR TREATING ALPHA-SYNUCLEIN-MEDIATED NEURODEGENERATION | WILSON, JERICA KATLYNN | — |
| 18569063 | CARDIOMYOCYTE SUBTYPES AND METHODS OF MAKING AND USING | UNDERDAHL, THANE E | — |
| 18288241 | MODIFIED ORGANS AND TISSUES | CHASE, CAROL ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023289 | COMPOSITIONS AND METHODS FOR GENERATING HUMAN YOLK SAC-LIKE HEMATOPOIETIC CELLS | STAVROU, CONSTANTINA E | 31d overdue |
| 18908568 | SYSTEM AND METHOD FOR REMOTE PATIENT MONITORING | NEWTON, CHAD A | 34d |
| 19025446 | PORTABLE IMAGING DEVICES, METHODS, AND SYSTEMS FOR WOUND IMAGING AND MONITORING | AKAR, SERKAN | 82d |
| 19081680 | METHOD AND SYSTEM FOR FLUORESCENCE IMAGING AND COLLECTION OF DATA FOR DIAGNOSTIC PURPOSES | AKAR, SERKAN | — |
| 19025038 | PORTABLE IMAGING DEVICES, METHODS, AND SYSTEMS FOR WOUND IMAGING AND MONITORING | AKAR, SERKAN | — |
| 18943247 | SYSTEMS, METHODS, AND DEVICES FOR THREE-DIMENSIONAL IMAGING, MEASUREMENT, AND DISPLAY OF WOUNDS AND TISSUE SPECIMENS | TALUKDER, MD K | — |
| 18899233 | NEUROTECHNOLOGY SYSTEM AND METHOD FOR MONITORING SEIZURE DEVELOPMENT AND ASSESSING ANTI-SEIZURE DRUG RESPONSE | CHNG, JOY POH AI | — |
| 18684053 | METHODS AND COMPOSITIONS FOR TREATING ALPHA-SYNUCLEIN-MEDIATED NEURODEGENERATION | WILSON, JERICA KATLYNN | — |
| Art Unit | Apps |
|---|---|
| 3797 | 4 |
| 1632 | 3 |
| 1633 | 2 |
| 3681 | 1 |
| 3686 | 1 |
| 1621 | 1 |
| 1699 | 1 |
| 1646 | 1 |
| 3791 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19081680 | METHOD AND SYSTEM FOR FLUORESCENCE IMAGING AND COLLECTION OF DATA FOR DIAGNOSTIC PURPOSES | AKAR, SERKAN | 3797 | §103 | Non-Final OA | — | Pending | Mar 17, 2025 |
| 19025038 | PORTABLE IMAGING DEVICES, METHODS, AND SYSTEMS FOR WOUND IMAGING AND MONITORING | AKAR, SERKAN | 3797 | §112 | Non-Final OA | — | Pending | Jan 16, 2025 |
| 19025446 | PORTABLE IMAGING DEVICES, METHODS, AND SYSTEMS FOR WOUND IMAGING AND MONITORING | AKAR, SERKAN | 3797 | DP | Final Rejection | 82d | Pending | Jan 16, 2025 |
| 18943247 | SYSTEMS, METHODS, AND DEVICES FOR THREE-DIMENSIONAL IMAGING, MEASUREMENT, AND DISPLAY OF WOUNDS AND TISSUE SPECIMENS | TALUKDER, MD K | — | Other | Non-Final OA | — | Pending | Nov 11, 2024 |
| 18908568 | SYSTEM AND METHOD FOR REMOTE PATIENT MONITORING | NEWTON, CHAD A | 3681 | §101§103 | Final Rejection | 34d | Pending | Oct 07, 2024 |
| 18899233 | NEUROTECHNOLOGY SYSTEM AND METHOD FOR MONITORING SEIZURE DEVELOPMENT AND ASSESSING ANTI-SEIZURE DRUG RESPONSE | CHNG, JOY POH AI | 3686 | §101§112 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18684053 | METHODS AND COMPOSITIONS FOR TREATING ALPHA-SYNUCLEIN-MEDIATED NEURODEGENERATION | WILSON, JERICA KATLYNN | 1621 | §102§103 | Final Rejection | — | Pending | Feb 15, 2024 |
| 18414178 | ANTI-TRANSTHYRETIN ANTIBODIES | FONTAINHAS, AURORA M | — | §112DP | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18578888 | PORPHYRIN NANOVESICLE WITH FATTY ACID CONJUGATE | MOSHER, ERIC PARKER | — | §103§112DP | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18569063 | CARDIOMYOCYTE SUBTYPES AND METHODS OF MAKING AND USING | UNDERDAHL, THANE E | 1699 | §101§102§103DPOther | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18288241 | MODIFIED ORGANS AND TISSUES | CHASE, CAROL ANN | 1646 | §102§103§112 | Non-Final OA | — | Pending | Oct 25, 2023 |
| 18555339 | POINT-OF-CARE PREDICTION OF MUSCLE RESPONSIVENESS TO THERAPY DURING NEUROREHABILITATION | AGAHI, PUYA | 3791 | §103§112 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18263658 | IMPROVED T-CELLS FOR CANCER THERAPY USING AMINO ACID STARVATION PATHWAYS | JUEDES, AMY E | 1644 | §102§103§112 | Non-Final OA | — | Pending | Jul 31, 2023 |
| 18255136 | METHODS AND USES FOR NDFIP1 FUSION POLYPEPTIDES IN TREATING NEURODEGENERATIVE DISEASES, BRAIN AND/OR TRAUMATIC AND NON-TRAUMATIC SPINAL CORD INJURIES, AND/OR OPTIC NEUROPATHIES | HELLMAN, KRISTINA M | 1654 | §103§112 | Non-Final OA | — | Pending | May 31, 2023 |
| 18044288 | METHODS FOR GENERATING NEURAL PROGENITOR CELLS WITH A SPINAL CORD IDENTITY | CONNORS, ALEXANDRA F | 1634 | §103§112 | Final Rejection | 45d overdue | Pending | Mar 07, 2023 |
| 18023289 | COMPOSITIONS AND METHODS FOR GENERATING HUMAN YOLK SAC-LIKE HEMATOPOIETIC CELLS | STAVROU, CONSTANTINA E | 1632 | §103 | Final Rejection | 31d overdue | Pending | Feb 24, 2023 |
| 17924040 | METHODS AND COMPOSITIONS FOR MAKING AND USING ENDOCARDIAL CELLS | ROGERS, ERIC JASON | 1638 | §102§103§112Other | Non-Final OA | 21d | Pending | Nov 08, 2022 |
| 17922731 | USE OF CD34 AS A MARKER FOR SINOATRIAL NODE-LIKE PACEMAKER CELLS | DHAR, MATASHA | 1632 | §112 | Final Rejection | 59d overdue | Pending | Nov 01, 2022 |
| 17915086 | METHODS, COMPOSITIONS, AND SYSTEMS FOR ENHANCING EX-VIVO ORGAN PERFUSION | NGUYEN, NGHI V | 1653 | §103 | Final Rejection | — | Pending | Sep 27, 2022 |
| 17782071 | GENETICALLY ENGINEERED DOUBLE NEGATIVE T CELLS AS AN ADOPTIVE CELLULAR THERAPY | ABUZEINEH, HANAN ISAM | 1633 | §103 | Non-Final OA | — | Pending | Jun 02, 2022 |
| 17744483 | SCREW-IN BIPOLAR ABLATION, MAPPING AND THERAPEUTIC CATHETER | HADDAD, MOUSSA MAHER | 3796 | §103 | Final Rejection | 22d | Pending | May 13, 2022 |
| 17642640 | DETECTION OF CIRCULATING TUMOR DNA USING DOUBLE STRANDED HYBRID CAPTURE | CASH, KAILEY ELIZABETH | 1683 | §103 | Non-Final OA | 22d | Pending | Mar 11, 2022 |
| 17620103 | FUROSEMIDE ANALOGUES AND COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ALZHEIMER'S DISEASE | CHENG, KAREN | 1623 | §102§103 | Non-Final OA | 23d | Pending | Dec 16, 2021 |
| 17616522 | METHODS OF MAKING AND USING LIVER CELLS | RAHMAN, MASUDUR | 1633 | §112 | Final Rejection | — | Pending | Dec 03, 2021 |
| 17509914 | METHOD AND SYSTEM FOR IMAGING AND COLLECTION OF DATA FOR DIAGNOSTIC PURPOSES | AKAR, SERKAN | 3797 | §112 | Non-Final OA | — | Pending | Oct 25, 2021 |
| 17413772 | BIOMARKER COMBINATIONS IN EX VIVO LUNG PERFUSION (EVLP) PERFUSATE | BORGEEST, CHRISTINA M | 1675 | §112DP | Final Rejection | — | Pending | Jun 14, 2021 |
| 17057130 | METHODS AND COMPOSITIONS COMPRISING TANKYRASE INHIBITORS FOR GENERATING INSULIN PRODUCING CELLS | STAVROU, CONSTANTINA E | 1632 | §103 | Final Rejection | — | Pending | Nov 20, 2020 |
| 16966293 | DEVICES, SYSTEMS, AND METHODS FOR TUMOR VISUALIZATION AND REMOVAL | TRUONG, MILTON LARSON | 3798 | §103 | Final Rejection | 29d | Pending | Jul 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial